Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesEfficacy and tolerability of urate lowering drugs in gout
Annals of Rheumatic Diseases, 04/29/08
Reinders MK et al. - This study demonstrates a poor efficacy and tolerability profile of allopurinol 300 mg/day to attain a biochemical predefined target level of sUr 0.30 mmol/l after 2-months treatment. In stage 2, benzbromarone 200 mg/day is more effective and better tolerated than probenecid 2000 mg/day.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Malignancy-associated multicentric reticulohistiocytosis
Rheumatology International, 12/20/09
Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil
Rheumatology, 12/18/09
Nicotine-patch therapy on mucocutaneous lesions of Behcet's disease: A case series
Rheumatology, 12/18/09
Today in Gout and Hyperuricemia...keeping you current
Receive free subspecialty "5-minute updates" via email
A clinical picture of chronic polyarticular tophaceous gout
Rheumatology International, 12/20/09
Hyperuricemia, Gout, and Renal Function After Liver Transplantation
Transplantation, 12/18/09
Taking the stress out of managing gout
Canadian Family Physician, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor